These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 16046935)
1. The role of intrathecal baclofen therapy in the upper motor neuron syndrome. Francisco GE Eura Medicophys; 2004 Jun; 40(2):131-43. PubMed ID: 16046935 [TBL] [Abstract][Full Text] [Related]
2. Principles of pharmaceutical management of spastic hypertonia. Elovic E Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):793-816, vii. PubMed ID: 11727721 [TBL] [Abstract][Full Text] [Related]
3. Limitations of intrathecal baclofen for spastic hemiparesis following stroke. Kofler M; Quirbach E; Schauer R; Singer M; Saltuari L Neurorehabil Neural Repair; 2009 Jan; 23(1):26-31. PubMed ID: 18796543 [TBL] [Abstract][Full Text] [Related]
4. The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Woon K; Tsegaye M; Vloeberghs MH Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454 [TBL] [Abstract][Full Text] [Related]
5. Intrathecal baclofen therapy for neurological disorders: a sound knowledge base but many challenges remain. Brennan PM; Whittle IR Br J Neurosurg; 2008 Aug; 22(4):508-19. PubMed ID: 18649160 [TBL] [Abstract][Full Text] [Related]
6. Intrathecal baclofen therapy: an update. Francisco GE; Saulino MF; Yablon SA; Turner M PM R; 2009 Sep; 1(9):852-8. PubMed ID: 19769920 [TBL] [Abstract][Full Text] [Related]
7. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. Motta F; Stignani C; Antonello CE J Pediatr Orthop; 2008 Mar; 28(2):213-7. PubMed ID: 18388717 [TBL] [Abstract][Full Text] [Related]
8. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy. Senaran H; Shah SA; Presedo A; Dabney KW; Glutting JW; Miller F Spine (Phila Pa 1976); 2007 Oct; 32(21):2348-54. PubMed ID: 17906577 [TBL] [Abstract][Full Text] [Related]
9. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief. McClelland S; Bethoux FA; Boulis NM; Sutliff MH; Stough DK; Schwetz KM; Gogol DM; Harrison M; Pioro EP Muscle Nerve; 2008 Mar; 37(3):396-8. PubMed ID: 17894358 [TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity. Bensmail D; Ward AB; Wissel J; Motta F; Saltuari L; Lissens J; Cros S; Beresniak A Neurorehabil Neural Repair; 2009; 23(6):546-52. PubMed ID: 19228818 [TBL] [Abstract][Full Text] [Related]
11. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study. Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS; Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820 [TBL] [Abstract][Full Text] [Related]
12. Intrathecal baclofen withdrawal resembling serotonin syndrome in an adolescent boy with cerebral palsy. Salazar ML; Eiland LS Pediatr Emerg Care; 2008 Oct; 24(10):691-3. PubMed ID: 19240673 [TBL] [Abstract][Full Text] [Related]
13. A review of the complications of intrathecal baclofen in patients with cerebral palsy. Kolaski K; Logan LR NeuroRehabilitation; 2007; 22(5):383-95. PubMed ID: 18162701 [TBL] [Abstract][Full Text] [Related]
14. Data condensed synthesis regarding kinesiotherapeutic procedures used in spasticity therapy. Moraru E; Onose G J Med Life; 2014 Sep; 7(3):317-21. PubMed ID: 25408747 [TBL] [Abstract][Full Text] [Related]
16. Intrathecal baclofen use in adults with cerebral palsy. Krach LE Dev Med Child Neurol; 2009 Oct; 51 Suppl 4():106-12. PubMed ID: 19740217 [TBL] [Abstract][Full Text] [Related]
17. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565 [TBL] [Abstract][Full Text] [Related]
18. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. McCoy AA; Fox MA; Schaubel DE; Ayyangar RN Arch Phys Med Rehabil; 2006 Nov; 87(11):1503-8. PubMed ID: 17084127 [TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. Stokic DS; Yablon SA; Hayes A Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946 [TBL] [Abstract][Full Text] [Related]